[1]
D. Sewda, M. Totade, B. Vikram, and A. K. Sharma, “A double-blind, placebo-controlled, randomized clinical trial to evaluate the efficacy and safety of Virulina® along with standard treatment as per hospital protocol for the treatment of novel coronavirus (COVID-19)”, J. Drug Delivery Ther., vol. 13, no. 9, pp. 91–97, Sep. 2023, doi: 10.22270/jddt.v13i9.6210.